The oral semaglutide race in India has hit a fresh legal hurdle. The Delhi High Court has asked Sun Pharma to seek its approval before launching the tablets.
Medical device industry groups are pushing back against the government's proposed regulatory framework. Eleven medtech groups have written to Union Health Minister J P Nadda seeking a separate law for medical devices.
The wellness market in India enters a transformative phase as Warburg Pincus moves to acquire Universal Nutriscience
Pharma regulation reform, cancer care access, and drug safety drive the latest developments in the pharmaceutical sector, as policymakers and companies have accelerated structural changes and healthcare outreach
Pharma companies in India face a stricter test as the Centre amends the Drugs Rules to debar companies that submit fake or fabricated data during drug approval applications
Aurobindo Pharma sets its sights on a USD 200 million revenue target from its TheraNym biologics venture by 2032
GLP-1 drug demand is reshaping global pharma economics, as Eli Lilly raised its 2026 sales in its obesity and diabetes portfolio
Alembic Pharma started FY27 with a strong first quarter. The company reported healthy growth in profit and revenue. Its performance was supported by new product launches, volume growth, and steady execution across key markets.
The dental implant safety framework is under consideration by the Central government as concerns grow over the quality, regulation, and long-term safety of dental implants used across India.
Bike ambulance services will gain regulatory clarity as India drafts new rules to strengthen emergency response systems, the proposal also introduces standards to ensure construction, safety, and functional compliance
, CDSCO.jpg)